This episode covers essential regulatory developments affecting pharmaceutical products and international sanctions within the Middle East. Key topics include the SFDA's enforcement actions on Monobenzone 20% Cream and Selsen Shampoo, alongside updates on sanctions targeting Hizballah, Da’esh, and entities on the SDN List.

The Saudi Food and Drug Authority (SFDA) has mandated recalls of all batches of Monobenzone 20% Cream manufactured by SACO MEDICAL, citing non-compliance with pharmaceutical regulations. Healthcare providers are instructed to halt dispensing and quarantine stock for return. Similarly, Selsen Shampoo has been recalled due to regulatory non-compliance, with protocols in place for managing remaining supplies and patient advisories.

On the sanctions front, the U.S. Treasury has increased sanctions on Hizballah, targeting networks smuggling millions in cash. Additionally, updates include amendments to the UN Security Council's Da’esh and Al-Qaida sanctions list and designations related to counter-narcotics and terrorism financing. These developments highlight ongoing international efforts to combat illicit networks and enforce compliance.

For more information, visit the Carver Agents website.

Articles mentioned:

1. 海外の医薬品簡略審査についてのページを更新しました。
2. Treasury Increases Sanctions on Hizballah and Targets Network Smuggling Millions in Cash for Hizballah
3. Treasury Increases Sanctions on Hizballah and Targets Network Smuggling Millions in Cash for Hizballah

1. سحب جميع تشغيلات مستحضر Selsen Shampoo
2. سحب جميع تشغيلات مستحضر Monobenzone 20% Cream

1. Counter Narcotics, Counter Terrorism, Cuba-related, and Iran-related Designations; Issuance of Russia-related General License; Issuance of Associated Frequently Asked Questions
2. Security Council ISIL (Da’esh) and Al-Qaida Sanctions Committee Amends 21 Entries on Its Sanctions List

1. سحب جميع تشغيلات مستحضر Monobenzone 20% Cream
2. سحب جميع تشغيلات مستحضر Selsen Shampoo